• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法国一家医院集团中器官获取成本评估的全国成本研究与医院成本核算对比

National cost study versus hospital cost accounting for organ recovery cost assessment in a French hospital group.

作者信息

Hrifach Abdelbaste, Ganne Christell, Couray-Targe Sandrine, Brault Coralie, Guerre Pascale, Serrier Hassan, Rabier Hugo, Grguric Gwen, Farge Pierre, Colin Cyrille

机构信息

1Pôle de Santé Publique, Service d'Evaluation Economique en Santé, Hospices Civils de Lyon, 162, Avenue Lacassagne - Bâtiment A, 69424 Lyon Cedex 03, France.

2HESPER EA 7425, Univ. Lyon, Université Claude Bernard Lyon 1, 69008 Lyon, France.

出版信息

Cost Eff Resour Alloc. 2018 Oct 11;16:34. doi: 10.1186/s12962-018-0155-2. eCollection 2018.

DOI:10.1186/s12962-018-0155-2
PMID:30356786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6190563/
Abstract

BACKGROUND

The choice of cost data sources is crucial, because it influences the results of cost studies, decisions of hospital managers and ultimately national directives of policy makers. The main objective of this study was to compare a hospital cost accounting system in a French hospital group and the national cost study (ENC) considering the cost of organ recovery procedures. The secondary objective was to compare these approaches to the weighting method used in the ENC to assess organ recovery costs.

METHODS

The resources consumed during the hospital stay and organ recovery procedure were identified and quantified retrospectively from hospital discharge abstracts and the national discharge abstract database. Identified items were valued using hospital cost accounting, followed by 2010-2011 ENC data, and then weighted using 2010-2011 ENC data. A Kruskal-Wallis test was used to determine whether at least two of the cost databases provided different results. Then, a Mann-Whitney test was used to compare the three cost databases.

RESULTS

The costs assessed using hospital cost accounting differed significantly from those obtained using the ENC data (Mann-Whitney; P-value < 0.001). In the ENC, the mean costs for hospital stays and organ recovery procedures were determined to be €4961 (SD €7295) and €862 (SD €887), respectively, versus €12,074 (SD €6956) and €4311 (SD €1738) for the hospital cost accounting assessment. The use of a weighted methodology reduced the differences observed between these two data sources.

CONCLUSIONS

Readers, hospital managers and decision makers must know the strengths and weaknesses of each database to interpret the results in an informed context.

摘要

背景

成本数据来源的选择至关重要,因为它会影响成本研究的结果、医院管理者的决策,并最终影响政策制定者的国家指令。本研究的主要目的是比较一家法国医院集团的医院成本核算系统与考虑器官回收程序成本的国家成本研究(ENC)。次要目的是比较这些方法与 ENC 中用于评估器官回收成本的加权方法。

方法

通过回顾医院出院摘要和国家出院摘要数据库,对住院期间和器官回收程序所消耗的资源进行识别和量化。使用医院成本核算对识别出的项目进行估值,然后使用 2010 - 2011 年 ENC 数据,并接着使用 2010 - 2011 年 ENC 数据进行加权。使用 Kruskal - Wallis 检验来确定至少两个成本数据库是否提供了不同的结果。然后,使用 Mann - Whitney 检验来比较这三个成本数据库。

结果

使用医院成本核算评估的成本与使用 ENC 数据获得的成本有显著差异(Mann - Whitney;P 值 < 0.001)。在 ENC 中,住院和器官回收程序的平均成本分别确定为 4961 欧元(标准差 7295 欧元)和 862 欧元(标准差 887 欧元),而医院成本核算评估的相应成本为 12074 欧元(标准差 6956 欧元)和 4311 欧元(标准差 1738 欧元)。使用加权方法减少了这两个数据源之间观察到的差异。

结论

读者、医院管理者和决策者必须了解每个数据库的优缺点,以便在知情的背景下解释结果。

相似文献

1
National cost study versus hospital cost accounting for organ recovery cost assessment in a French hospital group.法国一家医院集团中器官获取成本评估的全国成本研究与医院成本核算对比
Cost Eff Resour Alloc. 2018 Oct 11;16:34. doi: 10.1186/s12962-018-0155-2. eCollection 2018.
2
Organ recovery cost assessment in the French healthcare system from 2007 to 2014.2007 年至 2014 年法国医疗体系中器官回收成本评估。
Eur J Public Health. 2018 Jun 1;28(3):415-420. doi: 10.1093/eurpub/cky035.
3
Mixed method versus full top-down microcosting for organ recovery cost assessment in a French hospital group.法国一家医院集团中用于器官获取成本评估的混合方法与完全自上而下的微观成本核算方法比较
Health Econ Rev. 2016 Dec;6(1):53. doi: 10.1186/s13561-016-0133-3. Epub 2016 Nov 28.
4
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].[精神分裂症患者护理环境的成本效益分析:长效注射制剂下非典型抗精神病药物的影响]
Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5.
5
6
Length of stay has minimal impact on the cost of hospital admission.住院时长对住院费用的影响极小。
J Am Coll Surg. 2000 Aug;191(2):123-30. doi: 10.1016/s1072-7515(00)00352-5.
7
The Age of BLood Evaluation (ABLE) randomised controlled trial: description of the UK-funded arm of the international trial, the UK cost-utility analysis and secondary analyses exploring factors associated with health-related quality of life and health-care costs during the 12-month follow-up.BLood Evaluation (ABLE) 年龄随机对照试验:描述国际试验中英国资助的部分,英国成本效益分析,以及探索与 12 个月随访期间健康相关生活质量和医疗保健成本相关的次要分析。
Health Technol Assess. 2017 Oct;21(62):1-118. doi: 10.3310/hta21620.
8
What Are the Uses and Limitations of Time-driven Activity-based Costing in Total Joint Replacement?时间驱动作业成本法在全膝关节置换中的应用与局限是什么?
Clin Orthop Relat Res. 2019 Sep;477(9):2071-2081. doi: 10.1097/CORR.0000000000000765.
9
10

本文引用的文献

1
Organ recovery cost assessment in the French healthcare system from 2007 to 2014.2007 年至 2014 年法国医疗体系中器官回收成本评估。
Eur J Public Health. 2018 Jun 1;28(3):415-420. doi: 10.1093/eurpub/cky035.
2
Mixed method versus full top-down microcosting for organ recovery cost assessment in a French hospital group.法国一家医院集团中用于器官获取成本评估的混合方法与完全自上而下的微观成本核算方法比较
Health Econ Rev. 2016 Dec;6(1):53. doi: 10.1186/s13561-016-0133-3. Epub 2016 Nov 28.
3
Price-transparency and cost accounting: challenges for health care organizations in the consumer-driven era.价格透明度与成本核算:消费者驱动时代医疗保健机构面临的挑战
Inquiry. 2015 Apr 10;52. doi: 10.1177/0046958015574981. Print 2015.
4
DRG systems in Europe: variations in cost accounting systems among 12 countries.欧洲的疾病诊断相关分组(DRG)系统:12个国家成本核算系统的差异
Eur J Public Health. 2014 Dec;24(6):1023-8. doi: 10.1093/eurpub/cku025. Epub 2014 Mar 13.
5
Administrative and claims records as sources of health care cost data.作为医疗保健成本数据来源的行政和理赔记录。
Med Care. 2009 Jul;47(7 Suppl 1):S51-5. doi: 10.1097/MLR.0b013e31819c95aa.
6
Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source?癌症患者护理患病率成本估算方法的比较:数据源有何影响?
Med Care. 2009 Jul;47(7 Suppl 1):S64-9. doi: 10.1097/MLR.0b013e3181a23e25.
7
Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.估计结直肠癌患者护理发病成本方法的比较。
Med Care. 2009 Jul;47(7 Suppl 1):S56-63. doi: 10.1097/MLR.0b013e3181a4f482.
8
Inventory of data sources for estimating health care costs in the United States.美国医疗保健成本估算数据来源清单
Med Care. 2009 Jul;47(7 Suppl 1):S127-42. doi: 10.1097/MLR.0b013e3181a55c3e.
9
Health care costing: data, methods, current applications.医疗保健成本核算:数据、方法及当前应用
Med Care. 2009 Jul;47(7 Suppl 1):S1-6. doi: 10.1097/MLR.0b013e3181a7e401.
10
Hospital costs of renal transplant management.肾移植管理的医院费用。
Transplant Proc. 2008 Dec;40(10):3440-4. doi: 10.1016/j.transproceed.2008.03.177.